Which cancers is Nexavar (sorafenib tosilate) indicated to treat?

Nexavar (sorafenib tosilate) is indicated for hepatocellular carcinoma; advanced renal cell carcinoma after failure of interferon-alpha or interleukin-2-based therapy or when such therapy is unsuitable; and progressive, locally advanced or metastatic differentiated thyroid carcinoma (papillary, follicular or Hürthle cell) refractory to radioactive iodine.